Partnership between Oklo and Atomic Alchemy for isotope production

Oklo Inc. and Atomic Alchemy launch a partnership to increase the production of industrial and medical isotopes, essential in various sectors including cancer treatment.

Share:

Partenariat Oklo Atomic Alchemy Isotope

Comprehensive energy news coverage, updated nonstop

Annual subscription

8.25$/month*

*billed annually at 99$/year for the first year then 149,00$/year ​

Unlimited access • Archives included • Professional invoice

OTHER ACCESS OPTIONS

Monthly subscription

Unlimited access • Archives included

5.2$/month*
then 14.90$ per month thereafter

FREE ACCOUNT

3 articles offered per month

FREE

*Prices are excluding VAT, which may vary depending on your location or professional status

Since 2021: 35,000 articles • 150+ analyses per week

Against a backdrop of worldwide shortages of medical and industrial isotopes, Oklo Inc. and Atomic Alchemy announce strategic partnership to increase production of essential isotopes. This partnership leverages Oklo’s capabilities in fast fission technology and nuclear fuel recycling with Atomic Alchemy’s expertise in isotope production. Together, they plan to build and operate fast reactors that will not only be a source ofclean energy production, but also a platform for the production of vital isotopes for medical diagnostics, cancer treatment and industrial applications.

Technology and innovation at the heart of the partnership

Oklo’s fast reactors and advanced fuel recycling processes form the technological basis of this partnership. These technologies will enable the production of a wide range of isotopes, including those currently in critical short supply, such as those used in radioisotope thermoelectric generators and advanced cancer therapies. Oklo uses a reactor technology that optimizes the use of nuclear fuel and minimizes waste, while increasing the efficiency of isotope production.

Economic and security implications

This partnership is strategic not only from a technological point of view, but also from an economic and security one. By increasing domestic isotope production, the USA could reduce its dependence on foreign sources, often located in geopolitically unstable areas. This initiative is all the more relevant given that global demand for medical isotopes is rising steadily, fuelled by advances in cancer diagnosis and treatment technologies.

Challenges and prospects

The partnership between Oklo and Atomic Alchemy is not without its challenges. The complexity of isotope production requires considerable investment in research and development, as well as strict regulatory safeguards to ensure the safety and efficacy of the isotopes produced. However, the heads of both companies, Jacob DeWitte of Oklo and Thomas Eiden of Atomic Alchemy, are confident in their ability to overcome these obstacles thanks to their combined expertise and the support of their strategic and financial partners.
The partnership between Oklo and Atomic Alchemy is a bold step forward in securing the supply of isotopes vital to many sectors. It represents not only a technological breakthrough, but also a strategic initiative that could redefine energy production and public health standards in the United States.

Six European nuclear authorities have completed the second phase of a joint review of the Nuward modular reactor, a key step toward aligning regulatory frameworks for small nuclear reactors across Europe.
Driven by off-grid industrial heat demand and decarbonisation mandates, the global small modular reactor market is set to grow 24% annually through 2030, with installed capacity expected to triple within five years.
US fusion energy leaders have called on the federal government to redirect public funding towards their projects, arguing that large-scale investment is needed to stay competitive with China.
Santee Cooper has approved a memorandum of understanding with Brookfield Asset Management to assess the feasibility of restarting two unfinished nuclear reactors, with a potential $2.7 billion payment and 550 MW capacity stake.
Helical Fusion has signed a landmark agreement with Aoki Super to supply electricity from fusion, marking a first in Japan’s energy sector and a commercial step forward for the helical stellarator technology.
India’s nuclear capacity is expected to grow by more than 13,000 MW by 2032, driven by ongoing heavy water reactor construction, new regional projects and small modular reactor development by the Bhabha Atomic Research Centre.
NextEra Energy has lifted its earnings estimates for 2025 and 2026, supported by power demand linked to long‑term contracts previously signed with Google and Meta to supply their artificial intelligence data centres with low‑carbon electricity.
London launches a complete regulatory overhaul of its nuclear industry to shorten authorisation timelines, expand eligible sites, and lower construction and financing costs.
Finland's Ministry of Economic Affairs extends the deadline to June 2026 for the regulator to complete its review of the operating licence for the Olkiluoto spent nuclear fuel repository.
Framatome will replace several digital control systems at the Columbia plant in the United States under a contract awarded by Energy Northwest.
The conditional green light from the nuclear regulator moves Cigéo into its final regulatory stage, while shifting the risks towards financing, territorial negotiations and industrial execution.
The drone strike confirmed by the IAEA on the Chernobyl site vault exposes Ukraine to a nuclear risk under armed conflict, forcing the EBRD to finance partial restoration while industry standards must now account for drone threats.
Deep Fission is installing a 15 MWe pressurised reactor 1.6 km underground at Great Plains Industrial Park, under the Department of Energy’s accelerated pilot programme, targeting criticality by July 4, 2026.
EDF commits to supply 33 MW of nuclear electricity to Verkor over 12 years, enabling the battery manufacturer to stabilise energy costs ahead of launching its first Gigafactory.
The full-scope simulator for the Lianjiang nuclear project has successfully passed factory acceptance testing, paving the way for its installation at the construction site in China's Guangdong province.
A coalition of Danish industry groups, unions and investors launches a platform in support of modular nuclear power, aiming to develop firm low-carbon capacity to sustain industrial competitiveness.
The United Kingdom and TAE Technologies create a joint venture in Culham to produce neutral beams, a key component of fusion, with strategic backing from Google.
Texas-based developer Natura Resources receives new federal funding to test key components of its 100-megawatt modular reactor in partnership with Oak Ridge National Laboratory.
The Niigata regional assembly is deliberating on restarting unit 6 of the world’s largest nuclear plant, thirteen years after operations ceased following the Fukushima disaster.
Reactor Doel 2 was taken offline, becoming the fifth Belgian reactor to cease operations under the country’s gradual nuclear phase-out policy.

All the latest energy news, all the time

Annual subscription

8.25$/month*

*billed annually at 99$/year for the first year then 149,00$/year ​

Unlimited access - Archives included - Pro invoice

Monthly subscription

Unlimited access • Archives included

5.2$/month*
then 14.90$ per month thereafter

*Prices shown are exclusive of VAT, which may vary according to your location or professional status.

Since 2021: 30,000 articles - +150 analyses/week.